Detalles de la búsqueda
1.
The correlation between systemic inflammatory markers and efficiency for advanced gastric cancer patients treated with ICIs combined with chemotherapy.
Immunology
; 172(1): 77-90, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38269606
2.
Long-term survival after neoadjuvant therapy for triple-negative breast cancer under different treatment regimens: a systematic review and network meta-analysis.
BMC Cancer
; 24(1): 440, 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38594636
3.
Screening Single Nucleotide Polymorphisms Predicting the Efficacy of Electroacupuncture for Fatigue Treatment in Patients with Breast Cancer Following Adjuvant Chemotherapy.
Biochem Genet
; 62(2): 1291-1303, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37596508
4.
Therapeutic effect and metabolic fingerprinting of triple-negative breast cancer cells following exposure to a novel pH-responsive, gambogic acid-loaded micelle.
Nanotechnology
; 35(11)2023 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38081078
5.
Meta-analysis of quality of life in patients with cancer treated with antibody-drug conjugates in randomized controlled trials.
Future Oncol
; 19(32): 2201-2212, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37882431
6.
Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis.
BMC Cancer
; 21(1): 1261, 2021 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34814874
7.
A comparison between triplet and doublet chemotherapy in improving the survival of patients with advanced gastric cancer: a systematic review and meta-analysis.
BMC Cancer
; 19(1): 1125, 2019 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31747911
8.
Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: A systematic review and meta-analysis.
Spec Care Dentist
; 44(2): 530-541, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37219080
9.
Incidence of thyroid dysfunction caused by immune checkpoint inhibitors combined with chemotherapy: A systematic review and meta-analysis.
Int Immunopharmacol
; 133: 111961, 2024 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38608442
10.
Exploring GZMK as a prognostic marker and predictor of immunotherapy response in breast cancer: unveiling novel insights into treatment outcomes.
J Cancer Res Clin Oncol
; 150(6): 286, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38833021
11.
Efficacy and safety of first-line treatment for metastatic triple-negative breast cancer: A network meta-analysis.
Cancer Pathog Ther
; 2(2): 81-90, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38601487
12.
Incidence of antibody-drug conjugate-related fatigue in patients with breast cancer: A systematic review and meta-analysis.
Crit Rev Oncol Hematol
; 196: 104292, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38403093
13.
Comparative efficacy and safety of first-line neoadjuvant treatments in triple-negative breast cancer: systematic review and network meta-analysis.
Clin Exp Med
; 23(5): 1489-1499, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36152119
14.
Cyclin-dependent kinase 4 and 6 inhibitors in combination with neoadjuvant endocrine therapy in estrogen receptor-positive early breast cancer: a systematic review and meta-analysis.
Clin Exp Med
; 23(2): 245-254, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35304677
15.
The association between HER2-low expression and prognosis of breast cancer: a systematic review and meta-analysis.
Ther Adv Med Oncol
; 15: 17588359231156669, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36872948
16.
Watson for oncology decision system for treatment consistency study in breast cancer.
Clin Exp Med
; 23(5): 1649-1657, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36138331
17.
Incidence of antibody-drug conjugates-related pneumonitis in patients with solid tumors: A systematic review and meta-analysis.
Crit Rev Oncol Hematol
; 184: 103960, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36907365
18.
Treatment options for patients with human epidermal growth factor 2-positive breast cancer brain metastases: A systematic review and meta-analysis.
Front Oncol
; 13: 1003565, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36890831
19.
Second-line Endocrine Therapy of Hormone Receptor-positive/HER2- negative Advanced Breast Cancer: A Systematic Review and Network Meta-analysis.
Curr Cancer Drug Targets
; 23(9): 718-730, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37026492
20.
Development of Tumor Markers for Breast Cancer Immunotherapy.
Curr Mol Med
; 2023 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37157196